Windtree Therapeutics

Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the United States Patent and Trademark Office (USPTO) recently issued U.S. Patent No. 11,583,540, providing expanded patent coverage for istaroxime …

Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office Read More

business news

FullThrottle Technologies, LLC Announces Issuance of Patent for Company’s Proprietary First-Party Data Technologies

PHILADELPHIA, PA — FullThrottle Technologies, LLC this week announced the issuance of the company’s first patent by the United States Patent and Trademark Office. U.S. Patent No. 11,556,947 helps protect …

FullThrottle Technologies, LLC Announces Issuance of Patent for Company’s Proprietary First-Party Data Technologies Read More


Larimar Therapeutics

Larimar Therapeutics Announces Issuance of U.S. Patent Providing Composition of Matter Protection for CTI-1601

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced the recent issuance of U.S. Patent No. 11,459,363. The patent, titled, “Materials and Methods for Treating Friedreich’s Ataxia,” provides composition …

Larimar Therapeutics Announces Issuance of U.S. Patent Providing Composition of Matter Protection for CTI-1601 Read More